We crossed the start line!

This is the phrase our co-founder Caroline wrote to Annelyn a few days before the company was registered. As scientist, we always speak about bringing new discoveries to the bedside, to the pharmacy, to the patients. However, we always speak about it as a distant, unachievable future that we are not responsible to fulfill. It required a mindset shift, it required getting out of the lab and our comfort zones. Because new therapies require both, a business and a scientific strategy. And beyond those two elements, it also requires collaboration and trust; something we firmly believe in during the last decade we have been working together.

Sur180 Therapeutics has been founded to listen to women: to bring the best care possible believing that gynecological conditions seriously affect the quality of life of women, and it is time to change that.